|
9
|
88
|
8dquC |
Nanobody bound sars-cov-2 nsp9 |
|
22
|
166
|
7yev1 |
In situ structure of polymerase complex of mammalian reovirus in the pre-elongation state |
|
18
|
128
|
7yf01 |
In situ structure of polymerase complex of mammalian reovirus in the core |
|
22
|
166
|
7yez1 |
In situ structure of polymerase complex of mammalian reovirus in the reloaded state |
|
411
|
1750
|
7zuwCA |
Structure of rqt (c1) bound to the stalled ribosome in a disome unit from s. cerevisiae |
|
17
|
80
|
7qrfD |
Structure of the dimeric complex between precursor membrane ectodomain (prm) and envelope protein ectodomain (e) from tick-borne encephalitis virus |
|
76
|
398
|
7qrfA |
Structure of the dimeric complex between precursor membrane ectodomain (prm) and envelope protein ectodomain (e) from tick-borne encephalitis virus |
|
77
|
405
|
7qrgA |
Structure of the post-fusion complex between precursor membrane ectodomain (prm) and envelope ectodomain protein (e) from tick-borne encephalitis virus |
|
15
|
80
|
7qreD |
Structure of the hetero-tetramer complex between precursor membrane protein fragment (pr) and envelope protein (e) from tick-borne encephalitis virus |
|
14
|
80
|
7qrgD |
Structure of the post-fusion complex between precursor membrane ectodomain (prm) and envelope ectodomain protein (e) from tick-borne encephalitis virus |
|
77
|
400
|
7qreA |
Structure of the hetero-tetramer complex between precursor membrane protein fragment (pr) and envelope protein (e) from tick-borne encephalitis virus |
|
97
|
257
|
8bcrA |
Denv3 methyltransferase in complexed with at-9010 and sah |
|
119
|
443
|
8arpA |
Crystal structure of dead-box protein dbp2 in complex with adp |
|
116
|
440
|
8arkA |
Crystal structure of dead-box protein dbp2 in apo form |
|
83
|
301
|
7z2kA |
Crystal structure of sars-cov-2 main protease in orthorhombic space group p212121 |
|
74
|
304
|
7z3uA |
Crystal structure of sars-cov-2 main protease after incubation with sulfo-calpeptin |
|
82
|
300
|
7wqaA |
Sars-cov-2 main protease in complex with z-vad-fmk |
|
113
|
314
|
8dufA |
Crystal structure of venezuelan equine encephalitis alphavirus (veev) nonstructural protein 2 (nsp2) (k741a/k767a) protease domain |
|
77
|
305
|
8aebA |
Sars-cov-2 main protease complexed with n-(pyridin-3-ylmethyl)thioformamide |
|
18
|
100
|
8hk1E |
The cryo-em structure of human pre-17s u2 snrnp |
|
92
|
281
|
8f2eA |
Crystal structure of the cov-y domain of sars-cov-2 nonstructural protein 3 |
|
64
|
165
|
8c1aA |
Sars-cov-2 nsp3 macrodomain in complex with aztreonam |
|
64
|
165
|
8c19A |
Sars-cov-2 nsp3 macrodomain in complex with 1-methyl-4-[5-(morpholin-4-ylcarbonyl)-2-furyl]-1h-pyrrolo[2,3-b]pyridine |
|
82
|
298
|
8d35A |
Crystal structure of sars-cov-2 main protease (mpro) in complex with peptide from human trna methyltransferase trmt1 |
|
96
|
301
|
8c5mA |
Sars-cov-2 nsp10-16 methyltransferase in complex with mta |
|
27
|
115
|
8c5mB |
Sars-cov-2 nsp10-16 methyltransferase in complex with mta |
|
86
|
305
|
8b2tA |
Sars-cov-2 main protease (mpro) in complex with nirmatrelvir alkyne |
|
9
|
81
|
8fe3B |
Structure of dengue virus (denv2) in complex with prm12, an anti-prm monoclonal antibody |
|
38
|
394
|
8fe4A |
Structure of dengue virus (denv2) in complex with prm13, an anti-prm monoclonal antibody |
|
9
|
81
|
8fe4B |
Structure of dengue virus (denv2) in complex with prm13, an anti-prm monoclonal antibody |
|
37
|
394
|
8fe3A |
Structure of dengue virus (denv2) in complex with prm12, an anti-prm monoclonal antibody |
|
146
|
446
|
7wd4A |
Crystal structure of the ilheus virus helicase: implications for enzyme function and drug design |
|
98
|
262
|
7wnjA |
Crystal structure and cap binding analysis of the methyltransferase of langat virus |
|
84
|
306
|
7uu9A |
Crystal structure of the sars-cov-2 main protease in its apo-form |
|
84
|
306
|
7uueA |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi85 |
|
87
|
306
|
7uuaA |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi8 |
|
79
|
306
|
7uubA |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi12 |
|
83
|
306
|
7uu6A |
Crystal structure of the sars-cov-2 main protease in its apo-form |
|
81
|
306
|
7uu7A |
Crystal structure of the sars-cov-2 main protease in its apo-form |
|
81
|
306
|
7uu8A |
Crystal structure of the sars-cov-2 main protease in its apo-form |
|
87
|
306
|
7uudA |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi33 |
|
79
|
306
|
7uucA |
Structure of the sars-cov-2 main protease in complex with inhibitor mpi19 |
|
80
|
299
|
7pzqA |
Oxidized form of sars-cov-2 main protease determined by xfel radiation |
|
91
|
300
|
8bzvA |
Sars-cov-2 nsp10-16 methyltransferase in complex with adenosine |
|
34
|
133
|
7xhgA |
Crystal structure of the ntf2l domain of human g3bp1 in complex with the caprin-1 derived peptide |
|
26
|
116
|
8bzvB |
Sars-cov-2 nsp10-16 methyltransferase in complex with adenosine |
|
31
|
133
|
7xhfA |
Crystal structure of the ntf2l domain of human g3bp1 in complex with the usp10 derived peptide |
|
230
|
931
|
8gwfA |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
|
80
|
306
|
7pxzA |
Reduced form of sars-cov-2 main protease determined by xfel radiation |
|
101
|
593
|
8gwfE |
A mechanism for sars-cov-2 rna capping and its inhibition by nucleotide analogue inhibitors |
